Results 1 to 10 of about 4,120 (174)

Neurogenic orthostatic hypotension after treatment with sorafenib [PDF]

BMJ Case Reports, 2022
A man in his 70s with a history of fatigue, abdominal pain, and a palpable abdominal mass was found to have a peritoneal desmoid tumour. One year after diagnosis, he was prescribed sorafenib to limit tumour growth. Two months later, he developed dyspnoea on exertion and lower extremity weakness and was reported to have supine hypertension and ...
Catherine, Wegner Wippel, Hari, Deshpande, Huned, Patwa, Aldo J, Peixoto   +3 more
openaire   +3 more sources

Norepinephrine reuptake blockade to treat neurogenic orthostatic hypotension [PDF]

Clinical Autonomic Research, 2021
<jats:title>Abstract</jats:title><jats:p>GNSS satellite and receiving antennas exhibit group delay variations (GDV), which affect code pseudorange measurements. Like antenna phase center variations, which affect phase measurements, they are frequency-dependent and vary with the direction of the transmitted and received signal.
Eisenhofer, Graeme, Goldstein, David S.
openaire   +5 more sources

Neurogenic Orthostatic Hypotension. Lessons From Synucleinopathies [PDF]

American Journal of Hypertension, 2020
Abstract Maintenance of upright blood pressure critically depends on the autonomic nervous system and its failure leads to neurogenic orthostatic hypotension (NOH). The most severe cases are seen in neurodegenerative disorders caused by abnormal α-synuclein deposits: multiple system atrophy (MSA), Parkinson’s disease, Lewy body dementia,
Juan Francisco Idiaquez, Juan Idiaquez, Juan Carlos Casar, Italo Biaggioni   +3 more
openaire   +5 more sources

Neurogenic Orthostatic Hypotension in Parkinson Disease: A Primer [PDF]

Neurology and Therapy, 2019
Parkinson disease (PD) is associated with a variety of motor and non-motor clinical manifestations, including cardiovascular autonomic dysfunction. Neurogenic orthostatic hypotension (nOH) is a potentially serious manifestation of cardiovascular sympathetic failure that occurs in approximately 30% of patients with PD. Here we review the pathophysiology
Phillip A. Low, Jeremy K. Cutsforth-Gregory   +1 more
openaire   +4 more sources

Neurogenic Orthostatic Hypotension: State of the Art and Therapeutic Strategies [PDF]

Clinical Medicine Insights: Cardiology, 2020
Neurogenic orthostatic hypotension (nOH) is a subtype of orthostatic hypotension in which patients have impaired regulation of standing blood pressure due to autonomic dysfunction. Several primary and secondary causes of this disease exist. Patients may present with an array of symptoms making diagnosis difficult.
Dinesh K Kalra, Anvi Raina, Sumit Sohal
openaire   +5 more sources

Efficacy of atomoxetine versus midodrine for neurogenic orthostatic hypotension [PDF]

Annals of Clinical and Translational Neurology, 2019
AbstractObjectiveThe efficacy and safety of 1‐month atomoxetine and midodrine therapies were compared. Three‐month atomoxetine and combination therapies were investigated for additional benefits.MethodsThis prospective open‐label randomized trial included 50 patients with symptomatic neurogenic orthostatic hypotension (nOH).
Woo Jin Lee, Woo Jin Lee, Soon-Tae Lee, Soon-Tae Lee, Jung Ick Byun, Jung Ick Byun, Jung Ick Byun, Ki-Young Jung, Ki-Young Jung, Sang Kun Lee, Sang Kun Lee, Keun Hwa Jung, Keun Hwa Jung, Kon Chu, Kon Chu, Jun Sang Sunwoo, Do Yong Kim, Manho Kim, Manho Kim, Han Sang Lee, Han Sang Lee, Kyung Il Park, Hye Rim Shin, Hye Rim Shin, Jangsup Moon, Jangsup Moon   +25 more
openaire   +5 more sources

Six‐Month Use of Droxidopa for Neurogenic Orthostatic Hypotension [PDF]

Movement Disorders Clinical Practice, 2019
ABSTRACTBackgroundDroxidopa is approved for adult patients with symptomatic neurogenic orthostatic hypotension (nOH); there is limited information regarding effects on symptoms, outcomes, and quality of life (QOL) beyond two weeks of treatment.ObjectiveExamine the real‐world experience of patients taking droxidopa after six months of treatment ...
Kim McLeod, Clément François, Byron Padilla, Italo Biaggioni, Amy Duhig, Augustina Ogbonnaya, Joan Cannon, Steven Kymes, Cyndya A. Shibao, Binglin Yue, Laurie Orloski, Apryl Quillen   +11 more
openaire   +4 more sources

Neurogenic orthostatic hypotension: the very basics [PDF]

Clinical Autonomic Research, 2017
Horacio Kaufmann, Jose-Alberto Palma
openaire   +3 more sources

A validated test for neurogenic orthostatic hypotension at the bedside [PDF]

Annals of Neurology, 2018
Horacio Kaufmann, Lucy Norcliffe-Kaufmann, Jose-Alberto Palma   +2 more
openaire   +3 more sources

Primary neurogenic orthostatic hypotension [PDF]

Journal of Neurology, Neurosurgery & Psychiatry, 1970
Eight further cases of neurogenic orthostatic hypotension are described together with a necropsy study on one case. Three cases showed evidence of autonomic dysfunction in isolation, while in five cases this was accompanied by evidence of more diffuse central nervous system degeneration.
N. E. F. Cartlidge, R. C. Hughes, P. Millac   +2 more
openaire   +3 more sources